PNC Financial Services Group’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$47 Hold
5
– – ﹤0.01% 5171
2026
Q1
$46 Hold
5
– – ﹤0.01% 5129
2025
Q4
$37 Buy
+5
New +$36 ﹤0.01% 5110
2023
Q2
– Sell
-2,361
Closed -$2.53K – 4748
2023
Q1
$2.53K Buy
2,361
+1,168
+98% +$2.23K ﹤0.01% 4246
2022
Q4
$3.11K Buy
+1,193
New +$5.21K ﹤0.01% 4143
2022
Q3
– Sell
-2,303
Closed -$16K – 4453
2022
Q2
$16K Buy
2,303
+163
+8% +$1.66K ﹤0.01% 3589
2022
Q1
$30K Buy
2,140
+2,030
+1,845% +$27.2K ﹤0.01% 3375
2021
Q4
$2K Buy
110
+10
+10% +$142 ﹤0.01% 4128
2021
Q3
$1K Buy
100
+29
+41% +$446 ﹤0.01% 4177
2021
Q2
$1K Buy
+71
New +$1.14K ﹤0.01% 4095

Other funds holding BVS

PNC Financial Services Group's BVS Position: Q2 2026 in Review

PNC Financial Services Group held its Bioventus (BVS) position steady in Q2 2026 at 5 shares worth $47. The position accounts for ﹤0.01% of the portfolio, ranked #5171.

PNC Financial Services Group first reported a position in BVS in Q2 2021 and has held it in 10 quarters since. The position peaked at $30K in Q1 2022. 156 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • PNC Financial Services Group held 5 shares of Bioventus worth $47 as of Q2 2026.
  • PNC Financial Services Group left its Bioventus share count unchanged in Q2 2026.
  • Bioventus made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #5171 holding.
  • PNC Financial Services Group first reported a position in Bioventus in Q2 2021 and has held it in 10 quarters since.
  • PNC Financial Services Group's Bioventus position peaked at $30K in Q1 2022.
  • 156 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.